Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jan-Robert Schwark is active.

Publication


Featured researches published by Jan-Robert Schwark.


Pflügers Archiv: European Journal of Physiology | 1998

S3226, a novel inhibitor of Na+/H+ exchanger subtype 3 in various cell types

Jan-Robert Schwark; Hans Willi Jansen; Hans-Jochen Lang; Wolfgang Krick; Gerhard Burckhardt; Max Hropot

Abstract Inhibition of Na+/H+ exchange (NHE) subtypes has been investigated in a study of the mouse fibroblast L cell line (LAP1) transfected with human (h) NHE1, rabbit (rb) NHE2, rat (rt) or human (h) NHE3 as well as an opossum kidney cell line (OK) and porcine renal brush-border membrane vesicles (BBMV). S3226 {3-[2-(3-guanidino-2-methyl-3-oxo-propenyl)-5-methyl-phenyl]-N-isopropylidene-2-methyl-acrylamide dihydro-chloride} was the most potent and specific NHE3 inhibitor with an IC50 value of 0.02 µmol/l for the human isoform, whereas its IC50 value for hNHE1 and rbNHE2 was 3.6 and @80 µmol/l, respectively. In contrast, amiloride is a weak NHE3 inhibitor (IC50>100 µmol/l) with a higher affinity to hNHE1 and rbNHE2. Cariporide (4-isopropyl-3-methylsulphonyl-benzoyl-guanidine methane-sulphonate), which has an IC50 for NHE3 of approximately 1 mmol/l, is a highly selective NHE1 inhibitor (0.08 µmol/l). Therefore, S3226 is a novel tool with which to investigate the physiological and pathophysiological roles of NHE3 in animal models.


Pflügers Archiv: European Journal of Physiology | 1999

Selective inhibition of the Na+/H+ exchanger type 3 activates CO2/H+-sensitive medullary neurones.

Martin Wiemann; Jan-Robert Schwark; Udo Bonnet; Hans Willi Jansen; Sergio Grinstein; Robert E. Baker; Hans-Jochen Lang; Klaus Wirth; Dieter Bingmann

Abstract Hypercapnia as well as lowered intracellular pH (pHi) increase the bioelectric activity of CO2/H+-sensitive neurones (VLNcs) of the ventrolateral medulla oblongata. Here we describe that immunoreactive Na+/H+ exchanger (NHE3) is present in ventrolateral neurones from medullary organotypic cultures (obex level). To test whether VLNcs can be acidified and thereby activated by inhibition of NHE3, we used the novel high-affinity NHE3-inhibitors S1611 and S3226. Both drugs raised the firing rates of VLNcs to at least 150% of the control values, and depolarized membrane potential by up to 15 mV at concentrations (0.5–1 µmol/l) suitable for selective inhibition of NHE3. The changes in bioelectric activity strongly resembled the responses to hypercapnia (PCO2: 60–100 mmHg). In BCECF-AM-loaded cultures a subfraction of ventrolateral VLNcs was found to be intracellularly acidified by 0.05–0.1 pH units following treatment with S1611; the time course of this acidification was similar to that evoked by hypercapnia. All drug effects were sustained and readily reversible upon washing. Non-CO2/H+-responsive medullary neurones as well as hippocampal CA3 neurones were unaffected by up to 20 µmol/l S1611. It is concluded that the selective inhibition of NHE3 acidifies and activates CO2/H+-sensitive neurones within the ventrolateral medulla oblongata.


American Journal of Physiology-renal Physiology | 2000

Role of Na+/H+ exchanger NHE3 in nephron function: micropuncture studies with S3226, an inhibitor of NHE3

Volker Vallon; Jan-Robert Schwark; Kerstin Richter; Max Hropot


Archive | 1994

Benzocondensed five membered heterocycles, process of their preparation, their use as drug, as diagnostic means and pharmaceuticals containing it

Hans-Jochen Lang; Andreas Weichert; Jan-Robert Schwark; Wolfgang Scholz; Udo Albus; Peter Crause


Archive | 1997

Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them

Hans-Jochen Lang; Andreas Weichert; Jan-Robert Schwark; Wolfgang Scholz; Udo Albus; Peter Crause


Archive | 1994

Urea-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them

Jan-Robert Schwark; Hans-Jochen Lang; Heinz-Werner Kleemann; Andreas Weichert; Wolfgang Scholz; Udo Albus


Archive | 1995

Substituted N-heteroaroylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them

Heinz-Werner Kleemann; Hans-Jochen Lang; Jan-Robert Schwark; Andreas Weichert; Wolfgang Scholz; Udo Albus


Archive | 1994

Substituted benzoylguanidines, process for their preparation, their use as medicament, as inhibitor of the cellular Na+/H+ exchange or as diagnostic agent and medicament containing them

Hans-Jochen Lang; Andreas Weichert; Heinz-Werner Kleemann; Jan-Robert Schwark; Wolfgang Scholz; Udo Albus


Archive | 1994

Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them

Jan-Robert Schwark; Heinz-Werner Kleemann; Hans-Jochen Lang; Andreas Weichert; Wolfgang Scholz; Udo Albus


Archive | 1994

Orthosubstituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them

Andreas Weichert; Hans-Jochen Lang; Heinz-Werner Kleemann; Jan-Robert Schwark; Wolfgang Scholz; Udo Albus

Collaboration


Dive into the Jan-Robert Schwark's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Wolfgang Scholz

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge